Recent Press Releases

PRA Advances to Become PRA Health Sciences

RALEIGH, N.C., June 16, 2014 -- PRA, a leading clinical research organization, today announced that it has changed its name to PRA Health Sciences (PRA). The name change to PRA Health Sciences is the...

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA | Novotech, Australia's largest clinical CRO with offices throughout Asia, has signed an MOU with the Korea Drug Development Fund (KDDF) to promote the development of the Korean...

Quintiles and American Physical Therapy Association Announce Plans to Develop New Outcomes Registry

RESEARCH TRIANGLE PARK, N.C. and ALEXANDRIA, Va. – Quintiles and the American Physical Therapy Association (APTA) today announced a new strategic collaboration to develop and implement the...

Veristat and Karyopharm Therapeutics Inc. Enter into Preferred Provider Agreement for Oncology and Novel Therapeutic Advancement

HOLLISTON, Mass.--Veristat, a full service Contract Research Organization, announced today that Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the...

Oncobiologics launches Phase I Clinical Trial for ONS-3010 Biosimilar version of Humira®

CRANBURY, N.J. -- Oncobiologics, Inc. announced today that it has received approval to initiate a Phase I clinical trial in Europe for its first biosimilar molecule, ONS-3010, a highly biosimilar...

Leading Dermatology Contract Research Organization bioskin® Joins Medrio's Partner Program

NAPA, Calif. -- bioskin®, a leading dermatology CRO offering global clinical trial services, announces they have joined the Medrio partner program. Using Medrio's eClinical Software as a...

PAREXEL International Announces Stock Repurchase Program

BOSTON -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that its Board of Directors has approved a stock repurchase program authorizing the repurchase of up to $150 million of the...

Biotech Consortium Launches KPI Therapeutics, Inc., a New Collaborative Initiative to Speed Drug Development and Improve Investor Outcomes

SEATTLE--Five biotech firms and private investors have announced the launch of KPI Therapeutics, Inc. with the aim of speeding advancement of novel, promising drug candidates that can improve the...

Celerion Establishes Business Presence in Singapore and Appoints Dr. Chew Lan Chong as Executive Director, Medical Research

Celerion is pleased to announce the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Dr. Chew Lan Chong, MBBS, MRCS, MSc as Executive Director,...

TrialScope Acquires Deloitte Analytics LLC Assets Including PharmaCM Business

Creates industry-leading organization with proven solutions for ensuring compliance throughout the clinical trial process JERSEY CITY, N.J.-- TrialScope, a provider of clinical trial solutions and...

inVentiv Health and Aprecia Pharmaceuticals Form Innovative Partnership To Commercialize Aprecia's Unique Technology Platform

Aprecia is the first and only company offering the proprietary ZipDose® product platform that leverages three-dimensional printing (3DP) to create fast-melt pharmaceuticals inVentiv Health, the...

Bristol-Myers Squibb and Syngene International Extend Research Collaboration

PRINCETON, N.J. & BANGALORE, India--Bristol-Myers Squibb (NYSE:BMY) and Syngene International, India's largest contract research organization, today announced a five-year extension of their...

PharmaCell to Finalize Purchase of Cell Therapy Production Facility

Maastricht, The Netherlands, June 2, 2014 / B3C newswire / – PharmaCell B.V. a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe, announced...

PAREXEL Names Dr. Sy Pretorius Chief Scientific Officer

BOSTON, May 27, 2014 -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today named Dr. Sy Pretorius its Chief Scientific Officer. Dr. Pretorius...

AMRI to Acquire Oso Biopharmaceuticals Manufacturing

- Significantly Expands Contract Manufacturing Capabilities to Include Commercial Scale Sterile Injectables - ALBANY, N.Y., June 2, 2014 -- AMRI (NASDAQ: AMRI) today announced that it has...

WuXi PharmaTech Begins Operation of New High-Potency API Laboratory

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today...

INC Research Announces Partnership with Society for Clinical Research Sites

Partnership reinforces sites' pivotal role in clinical development, demonstrates Company's on-going commitment to fostering strong site relationships globally Raleigh, N.C. – INC...

Evotec to establish an anti-infectives platform with the acquisition of Euprotec Ltd

* Adds key know-how and infectious disease therapeutic area capabilities * Strengthens EVT Execute and EVT Innovate business by establishing an anti-infective platform * Initial purchase price of...

Advaxis Selects inVentiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates

PRINCETON, N.J. -- inVentiv Health Clinical, a leading global clinical research organization (CRO), and Advaxis, Inc. (NASDAQ: ADXS), a biotechnology company developing cancer immunotherapies,...

Simple Weighing with the New Sartorius Entris Balance

Goettingen, April 25, 2014 – Sartorius introduces the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions. The...